unca dep
600
Food supplement based on N-acetylcysteine and bromelain useful for promoting the fluidity of bronchial secretions.
It helps thin thick, sticky secretions, making them easier to expel, supports the function of the upper airways and helps protect against oxidative stress.
N-acetylcysteine Acetylcysteine (or N-Acetylcysteine or NAC) promotes the fluidity of thick, sticky secretions in the respiratory tract. As a precursor of glutathione, it helps protect the respiratory tract from oxidative stress.
3 Bromelain Bromelain, an enzyme with proteolytic activity extracted from the pineapple stem, supports microcirculatory function and the drainage of body fluids.
Gluten-free, glucose-free.
Ingredients | | per 1 sachet |
| N-Acetylcysteine | 600 mg |
| Bromelain from Pineapple (Ananas comosus) | 100 mg |
How to use Acute phase: two sachets a day, equal to 1.2 g of N-Acetylcysteine and 200 mg of Bromelain.
Maintenance phase: one sachet a day, equal to 600 mg of N-Acetylcysteine and 100 mg of Bromelain.
Warnings Pregnant or breastfeeding women and children should consult a doctor.
Do not exceed the recommended daily dose.
Keep out of the reach of children under three years of age.
Supplements should not be used as a substitute for a varied diet.
Do not give the product to children under three years of age.
Size Pack of 20 sachets of 6.5 g.
Bibliography - 1. Pela R, Calcagni AM, Subiaco S, et al. N-acetylcysteine reduces the exacerbation rate in patients with moderate to severe COPD. Respiration. 1999; 66:495-500.
- 2. Decramer M, Janssens W. Mucoactive therapy in COPD. Eur Respir Rev. 2010 Jun;19(116):134-40. Review.
- 3. Li XF, Ouyang B, Wu JF, Chen J, Guan XD. N-acetylcysteine (NAC) inhibited pulmonary fibrosis in acute respiratory distress syndrome (ARDS). Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2011 Oct;23(10):599-601.
- 4. Milara J, Juan G, Peiró T, Serrano A, Cortijo J. Neutrophil activation in severe, early-onset COPD patients versus healthy non-smoker subjects in vitro: effects of antioxidant therapy. Respiration. 2012;83(2):147-58.
- 5. Fitzhugh DJ, Shan S, Dewhirst MW et al. (2008). Bromelain treatment decreases neutrophil migration to sites of inflammation. Clin Immunol 128: 66–74.
- 6. Braun JM, Schneider B, Beuth HJ. Therapeutic use, efficiency and safety of the proteolytic pineapple enzyme Bromelain-POS in children with acute sinusitis in Germany. In Vivo 2005;19(2): 417–21.
- PDR®, Integratori nutrizionali, CEC Editore, from the 2nd English Ed. (2010).
- Council of Europe (2011), "European pharmacopoeia", VII edition, Strasbourg, Council of Europe.